128 related articles for article (PubMed ID: 6239430)
1. T suppressor cell function in cyclosporine-treated renal transplant recipients.
Brando B; Civati G; Busnach G; Grillo C; Minetti L
Transplant Proc; 1984 Dec; 16(6):1639-41. PubMed ID: 6239430
[No Abstract] [Full Text] [Related]
2. Suppression of second-set rejection by cyclosporine-resistant suppressor cells in a rat renal allograft model.
Freitas Rodrigues MA; Hutchinson IV; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):365-6. PubMed ID: 2523135
[No Abstract] [Full Text] [Related]
3. Lack of suppressor T cells in renal transplant recipients and activation by aminophylline.
Shohat B; Shapira Z; Joshua H; Servadio C
Thymus; 1983 Mar; 5(2):67-77. PubMed ID: 6222520
[TBL] [Abstract][Full Text] [Related]
4. Tempo of induction of W3/25+ suppressor cells in cyclosporine-treated rat cardiac allograft recipients.
Hall BM; Gurley KE; Dorsch SE
Transplant Proc; 1987 Feb; 19(1 Pt 1):504. PubMed ID: 2978917
[No Abstract] [Full Text] [Related]
5. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
[No Abstract] [Full Text] [Related]
6. Role of suppressor cells in cyclosporine-treated allograft recipients.
Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
[No Abstract] [Full Text] [Related]
7. Decreased interleukin 2 production and increased LEU 2a-positive suppressor cells in renal transplant patients on triple therapy with mizoribine, cyclosporine A, and prednisolone.
Okubo M; Kaneko Y; Mizukoshi M; Inoue K; Sato N; Kamata K; Chen XM; Uchida H; Endo T
Transplant Proc; 1987 Feb; 19(1 Pt 3):1940-3. PubMed ID: 2950635
[No Abstract] [Full Text] [Related]
8. Suppressor cell activity in human renal allograft recipients.
Hammer C; Land W; Castro LA
Proc Eur Dial Transplant Assoc; 1981; 18():454-8. PubMed ID: 6460247
[TBL] [Abstract][Full Text] [Related]
9. Suppressor cells influence maintenance and reversal of late rejection in indefinitely surviving skin allografts in cyclosporine-treated rats.
Thornburg LE; Padberg WM; Towpik E; Tilney NL
Transplant Proc; 1988 Jun; 20(3 Suppl 3):1025-30. PubMed ID: 2968692
[No Abstract] [Full Text] [Related]
10. Follow-up studies on proliferative T cell responses in cadaveric kidney graft recipients under combined immunosuppressive treatment with cyclosporine and prednisone.
Irschick EU; Niederwieser D; Lochs A; Spielberger M; Gattringer C; Margreiter R; Huber C
Immunobiology; 1985 Mar; 169(2):128-38. PubMed ID: 3158589
[TBL] [Abstract][Full Text] [Related]
11. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.
Thistlethwaite JR; Haag BW; Gaber AO; Stuart JK; Aronson AJ; Mayes JT; Lloyd DM; Stuart FP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1901-4. PubMed ID: 3103294
[No Abstract] [Full Text] [Related]
12. Differentiation of acute rejection from acute cyclosporine nephrotoxicity in renal transplants peripheral T cell subset counts.
Shen SY; Weir MR; Revie DR; Dagher FJ; Bentley FR; Chretien PB
Transplant Proc; 1987 Feb; 19(1 Pt 2):1776-9. PubMed ID: 2950634
[No Abstract] [Full Text] [Related]
13. Evaluation of lymphocyte subsets and suppressor cell function in long-term renal transplant recipients.
Redlich PN; Leapman SB; Marder P; Schmidtke J; Smith EJ; Fineberg N; Filo RS
Transplant Proc; 1984 Dec; 16(6):1555-7. PubMed ID: 6239424
[No Abstract] [Full Text] [Related]
14. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
[TBL] [Abstract][Full Text] [Related]
15. T cell subset analysis predicts virus infection but not rejection in cyclosporine A-treated renal allograft recipients.
Metselaar HJ; Jeekel J; Rothbarth PH; Vaessen LM; Wenting GJ; Weimar W
Transplant Proc; 1987 Feb; 19(1 Pt 3):2181-2. PubMed ID: 3274486
[No Abstract] [Full Text] [Related]
16. Lymphocyte subpopulations in renal biopsies of transplant patients treated with cyclosporine.
Lloveras J; Munne A; Serrano S; Corominas JM; Cuevas X; Masramon J
Transplant Proc; 1987 Feb; 19(1 Pt 2):1660-1. PubMed ID: 3274400
[No Abstract] [Full Text] [Related]
17. Lymphokine production in cyclosporine-treated renal transplant recipients.
McKenna RM; Rush DN; Bakkestad-Legare P; Jeffrey JR
Transplant Proc; 1988 Dec; 20(6):1245-7. PubMed ID: 3144073
[No Abstract] [Full Text] [Related]
18. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
20. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
